Ethereum pared some of its gains after hitting a multi-month high, following Bitcoins rise. It peaked at $3,446 and is ...

EUR/CAD declined to hit 9-month low on Friday after data showed Euro zone services activity contracted in November. Data ...

USD/ZAR steadied on Friday as U.S. dollar continued gain against emerging, commodity and risk currencies. U.S. dollar was boosted by haven buying as well as expectations that Trumps America-first ...

Ethers price continues to climb despite significant selling pressure from whales unloading over $1.3 billion in holdings. Investors anticipate a rally toward the $3,700 resistance level, buoyed by ...

Whale investors snapped up $35 million in Solana, driving the token to a new all-time high of $262. With growing excitement around a potential Solana ETF, analysts speculate that a climb to $5,000 ...

ETF Applications Boost Interest in Solana VanEck, 21Shares, Bitwise, and Canary Capital have filed applications for Solana exchange-traded funds (ETFs) with the U.S. SEC, and submitted to the Cboe ...

A single meme tweet from Elon Musk set the crypto world buzzing, with Dogecoins value surging 16.8% this week. The viral post, reminiscent of Musks 2021 DogeFather moment, highlights his knack for ...

On March 2 2022, delegates to the UN environment assembly adopted an ambitious resolution to develop the text of a new treaty by the end of 2024 to end plastic pollution. With 24 days of formal ...

The International Criminal Court issued arrest warrants on Nov. 21, 2024, for Israeli Prime Minister Benjamin Netanyahu, his former defense minister and one leading Hamas official. Those named in the ...

EconoTimes is a global, independent publication that delivers comprehensive news, analysis, and insights on the economy, finance, and markets. Based in Korea, we offer a unique perspective on global ...

After the conclusion of UN biodiversity conference Cop16, it was easy to feel disappointed. In Cali, Colombia, discussions ...

The United States Food and Drug Administration has just approved the first-ever clinical trial that uses CRISPR-Cas13 RNA editing. Its aim is to treat an eye disease called wet age-related macular ...